Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-15 Sale |
2020-10-16 6:55 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
15,000 | $40.49 | $607,392 | 1,276,511 (Indirect Direct) |
View |
| 2020-10-12 Sale |
2020-10-13 4:34 pm |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
35,264 | $42 | $1,481,088 | 1,279,319 (Direct) |
View |
| 2020-10-08 Sale |
2020-10-09 5:49 pm |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
44,574 | $41 | $1,827,534 | 1,369,015 (Direct) |
View |
| 2020-10-07 Sale |
2020-10-08 5:10 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
16,538 | $39.4 | $651,515 | 111,677 (Direct) |
View |
| 2020-10-06 Sale |
2020-10-08 5:03 pm |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
44,574 | $40 | $1,782,960 | 768,167 (Direct) |
View |
| 2020-10-06 Sale |
2020-10-08 5:01 pm |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
10,000 | $40 | $400,000 | 567,702 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-02 4:42 pm |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $36.52 | $912,913 | 577,702 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-02 4:40 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
9,752 | $36.37 | $354,662 | 128,215 (Direct) |
View |
| 2020-09-21 Sale |
2020-09-22 4:48 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
15,000 | $35.3 | $529,545 | 1,291,741 (Indirect Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 4:12 pm |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $35.36 | $883,966 | 602,702 (Direct) |
View |
| 2020-08-06 Sale |
2020-08-10 4:34 pm |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
37,445 | $37.47 | $1,403,031 | 19,678,861 (Indirect) |
View |
| 2020-08-03 Sale |
2020-08-05 5:09 pm |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
31,553 | $36.89 | $1,164,121 | 627,702 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-12 Exercise |
2020-10-13 4:34 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
35,264 | $2.27 | 1,279,319 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-13 4:34 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
35,264 | $0 | 1,279,319 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-09 5:49 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
35,264 | $2.27 | 1,369,015 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-09 5:49 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
35,264 | $0 | 1,369,015 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-08 5:03 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
35,264 | $2.27 | 768,167 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-08 5:03 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
35,264 | $0 | 768,167 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-08 5:01 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
10,000 | $2.27 | 567,702 (Direct) |
View |
| 2020-10-06 Exercise |
2020-10-08 5:01 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
10,000 | $0 | 567,702 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-02 4:42 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $2.27 | 577,702 (Direct) |
View |
| 2020-10-01 Exercise |
2020-10-02 4:42 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $0 | 577,702 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:12 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $2.27 | 602,702 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:12 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $0 | 602,702 (Direct) |
View |
| 2020-08-13 Exercise |
2020-08-14 4:04 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
32,451 | $2.27 | 812,023 (Direct) |
View |
| 2020-08-13 Exercise |
2020-08-14 4:04 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer |
32,451 | $0 | 812,023 (Direct) |
View |
| 2020-08-06 Other |
2020-08-10 4:34 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner |
962,555 | $0 | 19,678,861 (Indirect) |
View |
| 2020-08-03 Exercise |
2020-08-05 5:09 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $2.27 | 627,702 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 5:09 pm |
N/A 2028-06-25 |
Allogene Therapeutics Inc. | ALLO | Bhavnagri Veer General Counsel |
25,000 | $0 | 627,702 (Direct) |
View |